# Paul Stoffels

> Paul Stoffels is a Series C investor at Galapagos backing Biotechnology. See 0 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Galapagos](https://shizune.co/investors/profile/galapagos)
- Location: Mechelen, Belgium
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/stoffelspaul

Paul Stoffels is a Series C investor at Galapagos in Mechelen focused on Biotechnology and Pharmaceutical. Paul Stoffels is the MD, CEO and Chairman at Galapagos.

## Contacts

5 contacts available for Paul Stoffels: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/paul-stoffels?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 0% |
| Pharmaceutical | 1 | 0% |
| Artificial Intelligence | 1 | 0% |

## About Galapagos

VC Fund · Mechelen-bovelingen, Belgium

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

5 contacts available at Galapagos.

| Name | Title | Profile |
| --- | --- | --- |
| Andre Hoekema | Chief Business Officer | https://shizune.co/investors/profile/andre-hoekema |
| Kruti Popat | Director, Customer Insights & Engagement | https://shizune.co/investors/profile/kruti-popat |
| Michele Manto | Chief Commercial Officer | https://shizune.co/investors/profile/michele-manto |
| Paul Passier | Director Clinical Pharmacology | https://shizune.co/investors/profile/paul-passier |
| Paul Stoffels | Chief Executive Officer | https://shizune.co/investors/profile/paul-stoffels |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Paul Stoffels invest in?

Paul Stoffels invests primarily in Biotechnology, Pharmaceutical and Artificial Intelligence startups, most often at Series C stage. Most of the 0 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Paul Stoffels?

Public channels for Paul Stoffels include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co